The transcription factor ELF4 alleviates inflammatory bowel disease by activating IL1RN transcription, suppressing inflammatory TH17 cell activity, and inducing macrophage M2 polarization

BackgroundInflammatory bowel disease (IBD) is a chronic immune-mediated disorder affecting millions worldwide. Due to the complexity of its pathogenesis, the treatment options for IBD are limited. This study focuses on ELF4, a member of the ETS transcription factor family, as a target to elucidate i...

Full description

Bibliographic Details
Main Authors: Meiwan Cao, Peiyu Chen, Baoling Peng, Yang Cheng, Jing Xie, Ziang Hou, Huan Chen, Liping Ye, Huiwen Li, Hongli Wang, Lu Ren, Liya Xiong, Lanlan Geng, Sitang Gong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1270411/full